Table 3.
Case Scenarios
| Case Scenario and SpO2 Options | All Clinicians n (%) | Paramedic n (%) | Nurse n (%) | Doctor n (%) | Physiotherapist n (%) | P value |
|---|---|---|---|---|---|---|
| Mr Riley, a 56-year-old male admitted to hospital with an acute exacerbation of COPD | ||||||
| SpO2 88–92% | 80/115 (69.6) | 8/9 (88.9) | 40/59 (67.8) | 25/37 (67.6) | 7/10 (70.0) | 0.39 |
| SpO2 90–94% | 21/115 (18.3) | 0/9 (0.0) | 11/59 (18.6) | 9/37 (24.3) | 1/10 (10.0) | |
| SpO2 > 92% | 7/115 (6.1) | 1/9 (11.1) | 2/59 (3.4) | 3/37 (8.1) | 1/10 (10.0) | |
| SpO2 > 94% | 3/115 (2.6) | 0/9 (0.0) | 2/59 (3.4) | 0/37 (0.0) | 1/10 (10.0) | |
| SpO2 > 95% | 4/115 (3.5) | 0/9 (0.0) | 4/59 (6.8) | 0/37 (0.0) | 0/10 (0.0) | |
| Samantha Hood, a 22-year-old lady admitted with acute asthma | ||||||
| SpO2 88–92% | 2/115 (1.7) | 0/9 (0.0) | 2/58 (3.5) | 0/38 (0.0) | 0/10 (0.0) | 0.093 |
| SpO2 90–94% | 14/115 (12.2) | 0/9 (0.0) | 5/58 (8.6) | 9/38 (23.7) | 0/10 (0.0) | |
| SpO2 > 92% | 22/115 (19.1) | 1/9 (11.1) | 12/58 (20.7) | 8/38 (21.1) | 1/10 (10.0) | |
| SpO2 > 94% | 30/115 (26.1) | 6/9 (66.7) | 12/58 (20.7) | 10/38 (26.3) | 2/10 (20.0) | |
| SpO2 > 95% | 47/115 (40.9) | 2/9 (22.2) | 27/58 (46.6) | 11/38 (29.0) | 7/10 (70.0) | |
| Lois Lane, 82-year-old lady who is day 1 post right hip replacement with no other co-morbidities | ||||||
| SpO2 88–92% | 2/114 (1.8) | 1/9 (11.1) | 0/57 (0.0) | 1/38 (2.6) | 0/10 (0.0) | <0.001 |
| SpO2 90–94% | 19/114 (16.7) | 1/9 (11.1) | 6/57 (10.5) | 11/38 (29.0) | 1/10 (10.0) | |
| SpO2 > 92% | 32/114 (28.1) | 0/9 (0.0) | 12/57 (21.1) | 19/38 (50.0) | 1/10 (10.0) | |
| SpO2 > 94% | 29/114 (25.4) | 4/9 (44.4) | 14/57 (24.6) | 6/38 (15.8) | 5/10 (50.0) | |
| SpO2 > 95% | 32/114 (28.1) | 3/9 (33.3) | 25/57 (43.9) | 1/38 (2.6) | 3/10 (30.0) | |
| Tom Baker, 81-year-old obese man (BMI 32) who currently smokes. He is day 4 post cholecystectomy | ||||||
| SpO2 88–92% | 29/115 (25.2) | 1/9 (11.1) | 12/58 (20.7) | 12/38 (31.6) | 4/10 (40.0) | 0.027 |
| SpO2 90–94% | 32/115 (27.8) | 4/9 (44.4) | 12/58 (20.7) | 14/38 (36.8) | 2/10 (20.0) | |
| SpO2 > 92% | 24/115 (20.9) | 2/9 (22.2) | 13/58 (22.4) | 7/38 (18.4) | 2/10 (20.0) | |
| SpO2 > 94% | 16/115 (13.9) | 2/9 (22.2) | 7/58 (12.1) | 5/38 (13.16) | 2/10 (20.0) | |
| SpO2 > 95% | 14/115 (12.2) | 0/9 (0.0) | 14/58 (24.1) | 0/38 (0.0) | 0/10 (0.0) | |
Notes: where answers were listed that did not appear as part of the options, these have been treated as missing variables; n = number of respondents who chose scenario over total responses; p value denotes significant/non-significant difference between various clinical groups. Pseudonyms have been used in the hypothetical scenarios.